Avalo Therapeutics, Inc.
corporate_fare Company Profile
Avalo Therapeutics, Inc. (NASDAQ:AVTX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 26 items for AVTX at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Two Directors Depart Avalo Therapeutics Board Amidst Financial Challenges
- Avalo Therapeutics Reports Widened 2025 Net Loss, Increased Cash Burn, and Significant Dilution Potential Amidst Insider Selling Plans
- Avalo Therapeutics Reports 2025 Financials, Extends Cash Runway into 2028, and Anticipates Key Phase 2 Data in Q2 2026
- Officer Files Intent to Sell $466K in Shares Following Option Exercise
- Avalo Therapeutics Discloses $98M Cash, Extending Runway into 2028
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$59K
Net Income
-$78.26M
Diluted EPS
-$5.84
Op. Cash Flow
-$51.46M
Operating Income
-$72.92M
Cash & Equivalents
$15.86M
Debt / Equity
0.00×
Net Margin
-1326.42×
Shares Outstanding
18.51M sh
Source: 10-K · filed 2026-03-23 · accession 0001534120-26-000011
show_chartPrice Chart
Loading chart...
feed AVTX - Filings & News (Page 2)
AVTX
Mar 27, 2026, 4:01 PM EDT
Price at Filing:
$13.89
Real-time Price:
$6.76
Change:
-$7.13 (-51%)
Market Cap:
$390.884M
AVTX
Mar 23, 2026, 7:02 AM EDT
Price at Filing:
$13.40
Real-time Price:
$6.76
Change:
-$6.64 (-50%)
Market Cap:
$390.884M
AVTX
Mar 23, 2026, 7:01 AM EDT
Price at Filing:
$13.40
Real-time Price:
$6.76
Change:
-$6.64 (-50%)
Market Cap:
$390.884M
AVTX
Mar 16, 2026, 4:39 PM EDT
Price at Filing:
$16.02
Real-time Price:
$6.76
Change:
-$9.26 (-58%)
Market Cap:
$390.884M
AVTX
Jan 12, 2026, 7:53 AM EST
Price at Filing:
$16.95
Real-time Price:
$6.76
Change:
-$10.19 (-60%)
Market Cap:
$390.884M
AVTX
Jan 08, 2026, 4:01 PM EST
Price at Filing:
$17.11
Real-time Price:
$6.76
Change:
-$10.35 (-60%)
Market Cap:
$390.884M